The Food and Drug Administration announced Monday it is expanding emergency use authorization for Pfizer's COVID-19 vaccine to children ages 12-15.

The FDA action will be followed by the advisory committee's meeting, currently set for Wednesday. A draft agenda posted online says a vote would happen early Wednesday afternoon. If the committee gives the OK, the vaccines can then be distributed.

The agency said the two-dose vaccine has "met the statutory criteria" to allow the EUA to be amended, and says the "known and potential benefits of this vaccine in individuals 12 years of age and older outweigh the known and potential risks."

Nearly 35% of the U.S. population and 44% of adults have been fully vaccinated as of Monday, according to the CDC. That means people who have received both doses of either the Pfizer or Moderna vaccines, or the single-dose Johnson & Johnson vaccine. Forty-six percent of the population and 58.2% have received at least one dose of one of those vaccines. #WakeUpCLT #COVID19 #Verify

KEEP READING: [ Ссылка ]

свернуть